Evidence map›Paper›PMID 20484122›Full record

ArticleThe oncologist2010

Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study.

Lee W Jones, Marina Mourtzakis, Katherine B Peters, Allan H Friedman, Miranda J West, Stephanie K Mabe, William E Kraus, Henry S Friedman, David A Reardon

Open access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  7. Treatment Options for IDH-Mutant Malignant Gliomas.Current treatment options in oncology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Exercise preferences and associations between fitness parameters, physical activity, and quality of life in high-grade glioma patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  16. Review
  17. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Lee W JonesDuke University Medical Center, Durham, North Carolina 27710, USA. lee.w.jones@duke.edu
Marina Mourtzakis
Katherine B Peters
Allan H Friedman
Miranda J West
Stephanie K Mabe
William E Kraus
Henry S Friedman
David A Reardon
Duke Medical Center · USDuke University · USDurham University · GBUniversity of Waterloo · CA

Funding

Research Training in Age-Related Cognitive DisordersT32AG027668 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2007 to 2026
$6.3M
Changes in Functional Status Across Therapy for Primary GliomaR03CA126432 · NCI · DUKE UNIVERSITY · PI JONES, LEE W · 2006 to 2007
$154k
NCI NIH HHS CA-126432NCI NIH HHS R03 CA126432NIA NIH HHS T32 AG027668
6 · The paper itself

Abstract

purposeTo investigate the feasibility of longitudinal assessment of functional performance measures in newly diagnosed postsurgical malignant glioma patients.

methodsPatients with histologically confirmed, clinically stable, postsurgical, and previously untreated high-grade glioma (HGG) or low-grade glioma (LGG) were studied. Using a prospective design, all participants performed a cardiopulmonary exercise test with expired gas analysis to assess cardiorespiratory function (VO(2peak)) immediately following surgical resection (mean, 10 days). Additional functional outcomes were skeletal muscle cross-sectional area (CSA) via magnetic resonance imaging, isokinetic muscle strength (isokinetic dynamometry), and body composition (air displacement plethysmography). Quality of life (QOL) was assessed by the Functional Assessment of Cancer Therapy-Brain scale. All study assessments were repeated at 6 and 24 weeks following surgery.

resultsThirty-five patients (HGG, n = 25; LGG, n = 10) completed baseline assessments. Of these, 20 HGG (80%) and nine LGG (90%) and 15 HGG (60%) and nine LGG (90%) patients completed study assessments at 6 weeks and 24 weeks, respectively. Intention-to-treat analyses indicated several significant time-by-group interactions, with favorable improvements in functional and QOL endpoints from baseline to 24 weeks in the LGG cohort and unfavorable changes in the HGG cohort. Per-protocol analyses including participants assessed at all three study timepoints indicated significant improvements in VO(2peak) and fatigue from baseline to 24 weeks in the HGG cohort; peak workload, body composition, and muscle strength improved from baseline to 6 weeks (all p-values < .05).

conclusionsLongitudinal quantitative functional assessments are safe and feasible among select patients undergoing chemoradiation for primary malignant glioma. Large prospective studies investigating the clinical importance of these measures appear warranted.

Indexed as

AdultBrain NeoplasmsCombined Modality TherapyFeasibility StudiesGliomaHumansLongitudinal StudiesProspective StudiesQuality of Life

Identifiers

PMID20484122
PMCPMC3227991
OpenAlexW2145295241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.